Insights

Strategic exits Evolva recently divested assets to Lallemand and Vitilevure Danstar, indicating ongoing portfolio optimization and potential need for partnership in spin-off opportunities, licensing, or co-development deals to monetize remaining technologies.

Fermentation focus With core capabilities in fermentation and nature-based ingredient production, target customers in food, health, and wellness sectors seeking sustainable sourcing can be pursued for contract manufacturing, white-label ingredients, or turnkey supply arrangements.

Pet and animal health Launches of Veri-te PETS and related companion animal applications suggest a growing ecosystem for pet nutraceuticals; opportunities exist for collaborations with distributors, veterinary brands, and specialty retailers seeking clean-label, science-backed ingredients.

Academic and grant ties Past CDC grant support for tick bite prevention formulations signals openness to government and research collaborations; explore co-development, sponsored research, and grant-backed product expansions with health and preventive care markets.

Global and diverse A multinational team and a broad funding base imply capability for international business development, regulatory navigation, and multi-region go-to-market strategies; prioritize regional partners and distributors to accelerate market entry for sustainable bio-derived ingredients.

Similar companies to Evolva

Evolva Tech Stack

Evolva uses 8 technology products and services including jsDelivr, Open Graph, WordPress, and more. Explore Evolva's tech stack below.

  • jsDelivr
    Content Delivery Network
  • Open Graph
    Content Management System
  • Content Management System
  • MySQL
    Database
  • Email Delivery
  • The SEO Framework
    Search Engines
  • Google Tag Manager
    Tag Management

Media & News

Evolva's Email Address Formats

Evolva uses at least 4 email formats:
Evolva Email FormatsExamplePercentage
FirstL@evolva.comJohnD@evolva.com
87%
FirstLast@evolva.comJohnDoe@evolva.com
5%
FirstML@evolva.comJohnMD@evolva.com
5%
FirstLa@evolva.comJohnDo@evolva.com
3%

Frequently Asked Questions

What is Evolva's phone number?

Minus sign iconPlus sign icon
You can contact Evolva's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Evolva's stock symbol?

Minus sign iconPlus sign icon
Evolva is a publicly traded company; the company's stock symbol is ELVAY.

What is Evolva's official website and social media links?

Minus sign iconPlus sign icon
Evolva's official website is evolva.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Evolva generate?

Minus sign iconPlus sign icon
As of August 2026, Evolva's annual revenue is estimated to be $1M - $10M.

What is Evolva's SIC code and NAICS code?

Minus sign iconPlus sign icon
Evolva's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Evolva have currently?

Minus sign iconPlus sign icon
As of August 2026, Evolva has approximately 76 employees across 5 continents, including Europe, North America and Asia. Key team members include Cmo: N. B., Chief Operating Officer (products) Evolva Sa And Chief Executive Officer Evolva Inc: S. W. and Chief Operating Officer: G. L. Explore Evolva's employee directory with LeadIQ.

What industry does Evolva belong to?

Minus sign iconPlus sign icon
Evolva operates in the Biotechnology Research industry.

What technology does Evolva use?

Minus sign iconPlus sign icon
Evolva's tech stack includes jsDelivr, Open Graph, WordPress, MySQL, Microsoft 365, SendGrid, The SEO Framework and Google Tag Manager.

What is Evolva's email format?

Minus sign iconPlus sign icon
Evolva's email format typically follows the pattern of FirstL@evolva.com. Find more Evolva email formats with LeadIQ.

How much funding has Evolva raised to date?

Minus sign iconPlus sign icon
As of August 2026, Evolva has raised $110M in funding. The last funding round occurred on Oct 21, 2022 for $540K.
Evolva logo

Evolva

Biotechnology ResearchBasel-Landschaft, Switzerland51-200 Employees

Evolva is a mid-sized biotechnology research company based in Reinach, in the Basel-Landschaft region of Switzerland. It focuses on applying fermentation and related technology platforms to address bottlenecks in sourcing natural ingredients and to deliver nature-based compounds for health, wellbeing, and sensory experiences. The organization develops and commercializes ready-to-formulate ingredients that are designed to be high quality, affordable, and available in steady supply, with a diverse, interdisciplinary team guiding its work.

Its target markets include consumer products that rely on consistent, sustainable natural ingredients for health-related and sensory applications. Recent developments include the sale of Evolva's Swiss biotechnology business assets to Lallemand Inc., with the transaction closing in January 2024.

Section iconCompany Overview

Phone number
Website
evolva.com
SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
ELVAY
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
51-200

Section iconFunding & Financials

  • $110M

    Evolva has raised a total of $110M of funding over 10 rounds. Their latest funding round was raised on Oct 21, 2022 in the amount of $540K as a Grant.

  • $1M - $10M

    Evolva's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.